The novel p53 isoform "delta p53" is a misfolded protein and does not bind the p21 promoter site

被引:7
|
作者
Garcia-Alai, Maria M. [1 ]
Tidow, Henning [1 ]
Natan, Eviatar [1 ]
Townsley, Fiona M. [1 ]
Veprintsev, Dmitry B. [1 ]
Fersht, Alan R. [1 ]
机构
[1] MRC, Ctr Prot Engn, Cambridge CB2 0QH, England
基金
英国医学研究理事会;
关键词
protein structure/folding; structure/function studies; DNA-binding domains; dominant-negative mutation;
D O I
10.1110/ps.036996.108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor p53 can be expressed as different isoforms because of promoter selection and mRNA editing. One isoform, "delta p53'' (Delta p53), results from what would be an unusual alternative splicing of exons 7/8 of the p53 gene, conserving the reading frame and generating a novel protein with proposed transcriptional activity essential for the intra S-phase checkpoint. Here, we show that the deletion of the 66 residues that correspond to strand beta 10 and the C-terminal helix of the core domain and the interconnecting linker to the tetramerization domain occurring in the Delta p53 isoform leads to a misfolded and unstable protein, prone to form soluble aggregates, which does not bind the p21 promoter site. The complex of coexpressed Delta p53 and flp53 is soluble in vitro and binds poorly to DNA. Our results provide a structural explanation for the dominant-negative effect of Delta p53 and its lack of transcriptional activity.
引用
收藏
页码:1671 / 1678
页数:8
相关论文
共 50 条
  • [1] In vitro transcriptional activation of p21 promoter by p53
    Kim, TK
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 234 (02) : 300 - 302
  • [2] p53 interferes with HRX fusion protein activation of the p21 promoter.
    Payne, JM
    Tkachuk, DC
    BLOOD, 1999, 94 (10) : 178B - 178B
  • [3] p53 isoform delta133p53 in tumor senescence
    Von Muhlinen, Natalia
    Beck, Jessica
    Harris, Curtis C.
    CANCER RESEARCH, 2018, 78 (13)
  • [4] p53 binding to the p21 promoter is dependent on the nature of DNA damage
    Hill, Richard
    Bodzak, Ewelina
    Blough, Michael D.
    Lee, Patrick W. K.
    CELL CYCLE, 2008, 7 (16) : 2535 - 2543
  • [5] Modulation of p53 transcriptional activity by Delta40p53, a p53 isoform lacking the transactivation domain
    Hafsi, Hind
    Marcel, Virginie
    Hainaut, Pierre
    BULLETIN DU CANCER, 2011, 98 : S13 - S14
  • [6] Expression of p53 and p21 in primary glioblastomas
    Gross, MW
    Kraus, A
    Nashwan, K
    Mennel, HD
    Engenhart-Cabillic, R
    Schlegel, J
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 (03) : 164 - 171
  • [7] An embryonic tumor suppressor isoform, Δ40p53, stabilizes p53 and suppresses p21 in melanoma
    Takahashi, R.
    Markovic, S. N.
    Scrable, H. J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S23 - S23
  • [8] Hyperacetylation of the C-terminal domain of p53 inhibits the formation of the p53/p21 complex
    Kim, Ukjin
    Kim, Kwang Seok
    Park, Jong-Kuk
    Um, Hong -Duck
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 635 : 52 - 56
  • [9] Involvement of the p53/p21 complex in p53-dependent gene expression
    Kim, Ukjin
    Kim, Kwang Seok
    Park, Jong-Kuk
    Um, Hong -Duck
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 621 : 151 - 156
  • [10] Association of p53 and p21 polymorphisms with prostate cancer
    Sivonova, Monika Kmetova
    Vilckova, Marta
    Kliment, Jan
    Mahmood, Silvia
    Jurecekova, Jana
    Dusenkova, Svetlana
    Waczulikova, Iveta
    Slezak, Peter
    Dobrota, Dusan
    BIOMEDICAL REPORTS, 2015, 3 (05) : 707 - 714